glp-1 reta Retatrutide Weight Loss Retatrutide Promises Big Weight Loss,

M., Iqbal, N., et al

Initially developed for managing type 2 diabetes, Wegovy is approved for weight management and has demonstrated significant effectiveness in clinical trials

A recent study suggests that patients taking Ozempic and Wegovy may face an elevated risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition causing sudden vision loss

The results showed that MOTS-c treatment prevented obesity in mice fed a high-fat diet, but did not affect the weight of mice fed a normal diet (7)

Diabetes Care 48 , 292300 (2025)

Individual experiences vary and may not reflect typical results